Please wait a minute...
浙江大学学报（医学版）
浙江大学学报（医学版）  2020, Vol. 49 Issue (2): 170-177    DOI: 10.3785/j.issn.1008-9292.2020.02.04
指南与实践     
2019冠状病毒病(COVID-19)疫情期生物样本保藏生物安全防护原则及建议
张小燕(),孙伟,尚世强,毛建华,傅君芬,舒强,江克文*()
浙江大学医学院附属儿童医院生物样本库中心 国家儿童健康与疾病临床医学研究中心, 浙江 杭州 310051
Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19
ZHANG Xiaoyan(),SUN Wei,SHANG Shiqiang,MAO Jianhua,FU Junfen,SHU Qiang,JIANG Kewen*()
BioBank of Children's Hospital, Zhejiang University School of Medicine, National Clinical Research Center for Child Health, Hangzhou 310051, China
 全文: PDF(1070 KB)   HTML( 65 )
摘要：

严重急性呼吸综合征冠状病毒2（SARS-CoV-2）感染引起的2019冠状病毒病（COVID-19）是乙类传染病。随着COVID-19疫情蔓延，生物样本库样本保藏的生物安全风险增加，其生物安全防护显得越来越重要。根据国家有关规定和中华医学会相关指南，本文基于SARS-CoV-2病原学和COVID-19流行病学资料，提出了生物样本采集、转运、处理、保藏、检测、检测后处置、突发事件等过程中个人和生物样本保藏场所的生物安全防护原则及若干建议。强调依据有无病毒载量信息、传染力大小、标本类型（可能接触传播、气溶胶传播、粪口途径传播）对样本进行严格的生物安全风险评估，以指导疫情期间生物样本保藏、确保生物样本库生物安全。
关键词： 2019冠状病毒病;  严重急性呼吸综合征冠状病毒2;  新型冠状病毒肺炎;  生物标本库;  安全管理;  保存, 生物学    
Abstract:

Coronavirus disease 2019 (COVID-19) is a grade B infectious disease caused by severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2). In pace with the spreading of the disease, biosafety risk of the biological specimen preservation in biobanks has been significantly increased and biosafety protection during biological specimen preservation become increasingly important. According to the related national rules and the corresponding guidelines of Chinese Medical Association, this paper introduced the etiology about SARS-CoV-2, epidemiology about COVID-19, and the biosafety protection principles of individuals and biological specimen storage places in the process of personal protection, protection of collection, transport, handling, preservation, detection, post-detection disposal and emergencies of biological specimen. Emphasized to carry out a strict biosafety-risk assessment on biological specimen basing on virus load information, infectivity, and sample type (possible contact transmission, aerosol transmission, and fecal oral transmission).
Key words: Coronavirus disease 2019    Severe acute respiratory syndrome coronavirus 2    Novel coronavirus pneumonia    Biological specimen banks    Safety management    Preservation, biological
收稿日期: 2020-02-19 出版日期: 2020-02-28
:  Q-34  
基金资助: 浙江大学新型冠状病毒（2019-nCoV）肺炎应急科研专项；国家自然科学基金(81871012)
通讯作者: 江克文     E-mail: 21518309@zju.edu.cn;jiangkw_zju@zju.edu.cn
作者简介: 张小燕(1992-), 女, 硕士研究生, 实验员, 主要从事生物样本保藏工作和研究; E-mail:21518309@zju.edu.cn; https://orcid.org/0000-0002-6950-5096
服务　　
把本文推荐给朋友
加入引用管理器
E-mail Alert
RSS
作者相关文章　　
张小燕
孙伟
尚世强
毛建华
傅君芬
舒强
江克文

引用本文:

张小燕, 孙伟, 尚世强, 毛建华, 傅君芬, 舒强, 江克文. 2019冠状病毒病(COVID-19)疫情期生物样本保藏生物安全防护原则及建议[J]. 浙江大学学报（医学版）, 2020, 49(2): 170-177.

ZHANG Xiaoyan, SUN Wei, SHANG Shiqiang, MAO Jianhua, FU Junfen, SHU Qiang, JIANG Kewen. Principles and suggestions on biosafety protection of biological specimen preservation during prevalence of COVID-19. J Zhejiang Univ (Med Sci), 2020, 49(2): 170-177.

链接本文:

http://www.zjujournals.com/med/CN/10.3785/j.issn.1008-9292.2020.02.04    或    http://www.zjujournals.com/med/CN/Y2020/V49/I2/170

1 全国人民代表大会常务委员会.中华人民共和国传染病防治法[Z/OL].[2020-02-10].http://www.npc.gov.cn/npc/c238/202001/099a493d03774811b058f0f0ece38078.shtml.
The National People's Congress of the People's Republic of China. Law of the People's Republic of China on prevention and control of infectious diseases[Z/OL].[2020-02-10]. http://www.npc.gov.cn/npc/c238/202001/099a493d03774811b058f0f0ece38078.shtml. (in Chinese)
2 中华人民共和国国家卫生健康委员会办公厅, 国家中医药管理局办公室.新型冠状病毒感染的肺炎诊疗方案(试行第六版)[A/OL].国卫办医涵[2020] 145号.(2020-02-18)[2020-02-28].http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml.
General Office of National Health Commission of the People's Republic of China, Office of National Administration of Traditional Chinese Medicine. Diagnosis and treatment of novel coronavirus pneumonia (trial version 6)[A/OL]. No.145[2020] of the General Office of the National Health Commission. (2020-02-18)[2020-02-28]. http://www.nhc.gov.cn/yzygj/s7653p/202002/8334a8326dd94d329df351d7da8aefc2.shtml. (in Chinese)
3 中华人民共和国国家卫生健康委员会办公厅.新型冠状病毒实验室生物安全指南(第二版)[A/OL].国卫办科教函[2020] 70号.(2020-01-23)[2020-02-28].http://www.nhc.gov.cn/xcs/zhengcwj/202001/0909555408d842a58828611dde2e6a26.shtml.
General Office of National Health Commission of the People's Republic of China. Laboratory biosafety guide of 2019 novel coronavirus (version 2)[A/OL]. No.70[2020] of the General Office of the National Health Commission. (2020-01-23)[2020-02-28]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/0909555408d842a58828611dde2e6a26.shtml. (in Chinese)
4 中华人民共和国国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎防控方案(第三版)[A/OL].国卫办疾控函[2020] 80号.(2020-01-28)[2020-02-28].http://www.nhc.gov.cn/jkj/s7923/202001/470b128513fe46f086d79667db9f76a5.shtml.
General Office of National Health Commission of the People's Republic of China. Prevention of pneumonia caused by novel coronavirus (version 3)[A/OL].No.80[2020] of the General Office of the National Health Commission. (2020-01-28)[2020-02-28]. http://www.nhc.gov.cn/jkj/s7923/202001/470b128513fe46f086d79667db9f76a5.shtml. (in Chinese)
5 中华人民共和国国家卫生健康委员会办公厅.新型冠状病毒感染的肺炎防控中常见医用防护用品使用范围指引(试行)[A/OL].国卫办医函[2020] 75号.(2020-01-27)[2020-02-28].http://www.nhc.gov.cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c6.shtml.
General Office of National Health Commission of the People's Republic of China. Guidelines for the use of common medical protective products in the prevention and control of pneumonia due to new coronavirus infection (trial version)[A/OL]. No.75[2020] of the General Office of the National Health Commission. (2020-01-27)[2020-02-28]. http://www.nhc.gov.cn/xcs/zhengcwj/202001/e71c5de925a64eafbe1ce790debab5c6.shtml. (in Chinese)
6 中华人民共和国国务院.病原微生物实验室生物安全管理条例[A/OL].国务院令第424号.(2004-11-12)[2020-02-28].http://www.gov.cn/zhengce/content/2008-03/28/content_6264.htm.
State Council of the People's Republic of China. Regulations on biological safety management of pathogenic microbial laboratories[A/OL]. Decree No. 424 of the State Council. (2004-11-12)[2020-02-28]. http://www.gov.cn/zhengce/content/2008-03/28/content_6264.htm. (in Chinese)
7 中华医学会检验医学分会.2019新型冠状病毒肺炎临床实验室检测的生物安全防护指南(试行第一版)[A/OL].(2020-01-30)[2020-02-28].http://www.cslm.org.cn/cn/news.asp?id=73.html.
Chinese Society of Laboratory Medicine. Biosafety protection guidelines for clinical laboratory testing of 2019 novel coronavirus pneumonia (trial version 1)[A/OL]. (2020-01-30)[2020-02-28]. http://www.cslm.org.cn/cn/news.asp?id=73.html. (in Chinese)
8 中华医学会检验医学分会 . 新型冠状病毒肺炎病毒核酸检测专家共识[J]. 中华医学杂志, 2020, 100 (00): E003- E003-
Chinese Society of Laboratory Medicine . Expert consensus on nucleic acid detection of new coronavirus pneumonia virus[J]. National Medical Journal of China, 2020, 100 (00): E003- E003
doi: 10.3760/cma.j.issn.0376-2491.2020.0003
9 Centers for Disease Control and Prevention. Interim guidelines for collecting, handling, and testing clinical specimens from patients under investigation (PUIs) for 2019 novel coronavirus (2019-nCoV)[EB/OL]. (2020-02-02)[2020-02-28]. https://www.cdc.gov/coronavirus/2019-ncov/lab/guidelines-clinical-specimens.html.
10 World Health Organization. Risk communication and community engagement (RCCE) readiness and response to the 2019 novel coronavirus (2019-nCoV) Interim guidance, Interim guidance v2[EB/OL]. (2020-01-26)[2020-02-28]. https://www.who.int/publications-detail/risk-communication-and-community-engagement-readiness-and-initial-response-for-novel-coronaviruses-(-ncov).
11 HOLSHUE M L , DEBOLT C , LINDQUIST S et al. First case of 2019 novel coronavirus in the united states[J]. N Engl J Med, 2020, 382 (10):
doi: 10.1056/NEJMoa2001191
12 XIA J , TONG J , LIU M et al. Evaluation of coronavirus in tears and conjunctival secretions of patients with SARS-CoV-2 infection[J]. J Med Virol, 2020, 1- 6
doi: 10.1002/jmv.25725
13 WS/T511-2016经空气传播疾病医院感染预防与控制规范[J].中国感染控制杂志, 2017, 16(5): 490-492. DOI: 10.3969/j.issn.1671-9638.2017.05.023.
WS/T511-2016 Guideline for prevention and control of nosocomial infections through airborne diseases[J]. Chinese Journal of Infection Control, 2017, 16(5): 490-492. DOI: 10.3969/j.issn.1671-9638.2017.05.023.(inChinese)
14 中华人民共和国国家质量监督检验检疫总局, 中国国家标准化管理委员会.GB 19258-2012紫外线杀菌灯[S].北京: 中国标准出版社, 2012.
General Administration of Quality Supervision, Inspection and Quarantine of the People's Republic of China, Standardization Administration of China. GB 19258-2012 UV germicidal lamp[S]. Beijing: China Standard Press, 2012. (in Chinese)
15 浙江省病原微生物实验室生物安全质量管理中心.生物安全实验室建设与管理[M].杭州: 浙江文艺出版社, 2019.
Pathogen Microbiology Laboratory Biosafety Quality Management Center of Zhejiang Province. Construction and management of biosafety laboratories[M]. Hangzhou: Zhejiang Literature and Art Publishing House, 2019. (in Chinese)
16 中华人民共和国卫生部.可感染人类的高致病性病原微生物菌(毒)种或样本运输管理规定[S/OL].中华人民共和国卫生部令(第45号).(2005-12-28)[2020-02-28]. http://www.nhc.gov.cn/qjjys/s3589/200804/081c1f4c9a934fda887c1534abb3dd94.shtml.
Ministry of Health of the People's Republic of China. Regulations on the management of transportation of highly pathogenic pathogenic microorganisms (toxins) or samples that can infect humans[S/OL]. Decree No. 45 of the National Ministry of Health. (2005-12-28)[2020-02-28]. http://www.nhc.gov.cn/qjjys/s3589/200804/081c1f4c9a934fda887c1534abb3dd94.shtml. (in Chinese)
[1] 王锦程,刘锦鹏,王园园,刘伟,陈小群,孙超,沈晓勇,汪启东,吴亚平,梁文杰,阮凌翔. 2019冠状病毒病(COVID-19)患者胸部CT影像学动态变化[J]. 浙江大学学报（医学版）, 2020, 49(2): 191-197.
[2] 曹盛力,冯沛华,时朋朋. 修正SEIR传染病动力学模型应用于湖北省2019冠状病毒病(COVID-19)疫情预测和评估[J]. 浙江大学学报（医学版）, 2020, 49(2): 178-184.
[3] 陈军,刘丹萍,刘莉,刘萍,徐庆年,夏露,凌云,黄丹,宋树丽,张丹丹,钱志平,李涛,沈银忠,卢洪洲. 硫酸羟氯喹治疗2019冠状病毒病(COVID-19)普通型患者的初步研究[J]. 浙江大学学报（医学版）, 2020, 49(2): 215-219.
[4] 陈志敏,傅君芬,舒强,汪伟,陈英虎,华春珍,李甫棒,林茹,唐兰芳,汪天林,王颖硕,徐玮泽,杨子浩,叶盛,袁天明,张晨美,张园园. 儿童2019冠状病毒病(COVID-19)诊疗指南(第二版)[J]. 浙江大学学报（医学版）, 2020, 49(2): 139-146.
[5] 徐凯进,蔡洪流,沈毅弘,倪勤,陈瑜,胡少华,李剑平,王华芬,俞亮,黄河,裘云庆,魏国庆,方强,周建英,盛吉芳,梁廷波,李兰娟. 2019冠状病毒病(COVID-19)诊疗浙江经验[J]. 浙江大学学报（医学版）, 2020, 49(2): 147-157.
[6] 姜赛平,李璐,茹仁萍,张春红,饶跃峰,林彬,王融溶,陈娜,王小娟,蔡洪流,盛吉芳,周建英,卢晓阳,裘云庆. 2019冠状病毒病(COVID-19)重型、危重型患者用药管理经验[J]. 浙江大学学报（医学版）, 2020, 49(2): 158-169.
[7] 李鑫,代甜,王虹,石军年,袁薇,栗静,陈利军,张天明,张珊珊,孔焱,岳宁,时慧,何玉苹,胡惠芳,柳芙蓉,杨彩霞. 2019冠状病毒病(COVID-19)疑似患者合并焦虑和抑郁的临床分析[J]. 浙江大学学报（医学版）, 2020, 49(2): 203-208.
[8] 骆嵩,杨丽娟,王春,刘传苗,李殿明. 血浆置换和托珠单抗治疗六例2019冠状病毒病(COVID-19)重型患者临床分析[J]. 浙江大学学报（医学版）, 2020, 49(2): 227-231.
[9] 洪东升,倪剑,单文雅,李璐,胡希,羊红玉,赵青威,张幸国. 基于监测数据的药物不良反应快速识别及R语言实现[J]. 浙江大学学报（医学版）, 2020, 49(2): 253-259.
[10] 钟琦,李志,沈晓勇,徐凯进,沈毅弘,方强,陈峰,梁廷波. 2019冠状病毒病(COVID-19)不同临床分型患者胸部CT影像学特征[J]. 浙江大学学报（医学版）, 2020, 49(2): 198-202.
[11] 康仙慧,张荣,何慧梁,姚永兴,郑跃英,温小红,祝胜美. 一例妊娠合并2019冠状病毒病(COVID-19)患者的剖宫产麻醉管理[J]. 浙江大学学报（医学版）, 2020, 49(2): 249-252.
[12] 陈旭,李央,王金希,蔡洪流,曹红翠,盛吉芳. 三例妊娠合并2019冠状病毒病(COVID-19)患者诊治分析[J]. 浙江大学学报（医学版）, 2020, 49(2): 240-244.
[13] 沈利华,黄菲,陈祥,熊钻,杨晓玉,李慧,程丰,郭健,龚国富. 严重急性呼吸综合征冠状病毒2(SARS-CoV-2)核酸检测试剂盒临床诊断效能评估[J]. 浙江大学学报（医学版）, 2020, 49(2): 185-190.
[14] 张胜,李丹萍,陈华忠,郑丹,周益萍,陈葆国,石卫武,林荣海. 糖皮质激素治疗一例2019冠状病毒病(COVID-19)危重型患者炎症反应动态观察[J]. 浙江大学学报（医学版）, 2020, 49(2): 220-226.
[15] 李游江,胡瑛瑛,张晓东,喻员员,李斌,吴建国,吴英萍,夏肖萍,徐键. 七例2019冠状病毒病(COVID-19)普通型患者出院后病毒核酸随访结果[J]. 浙江大学学报（医学版）, 2020, 49(2): 270-274.